Vitrafy enters a partnership with Vitalant Innovation Center
Open PDF
| Stock | VFY.ASX (VFY.ASX) |
|---|---|
| Release Time | 2 Jun 2026, 10:08 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Vitrafy Partners with Vitalant for Cryopreservation Ecosystem
Key Points
- Vitrafy partners with Vitalant Innovation Center to address RBC preservation crisis
- Vitalant is the second-largest blood network in the USA
- Partnership aims to replace legacy technologies by 2027
- Opportunity to expand to other blood products
Full Summary
Vitrafy Life Sciences Limited has announced a partnership with Vitalant Innovation Center to configure its next-generation cryopreservation ecosystem, aiming to solve the looming crisis for red blood cell preservation. Vitalant, the second-largest blood network in the USA, will contribute resources to deliver a market-wide solution. The partnership addresses the discontinuation of legacy technologies used to cryopreserve red blood cells, which are critical for long-term stockpiling and emergency supply readiness. Vitrafy plans to expand this solution to other blood products, potentially becoming the successor to existing end-of-life legacy technologies across the U.S. blood network.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In